eFFECTOR Therapeutics, Inc. (EFTR)

NASDAQ: EFTR · IEX Real-Time Price · USD

1.810

-0.040 (-2.16%)

At close: Apr 25, 2024, 4:00 PM

1.840

+0.030 (1.66%)

After-hours: Apr 25, 2024, 7:57 PM EDT

eFFECTOR Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019
Revenue	0	3.55	1.43	42	0
Revenue Growth (YoY)	-	148.46%	-96.60%	-	-
Gross Profit	0	3.55	1.43	42	0
Selling, General & Admin	10.93	12.64	13.37	4.35	4.72
Research & Development	22.92	23.31	19.96	21.83	23.89
Operating Expenses	33.84	35.96	33.33	26.18	28.61
Operating Income	-33.84	-32.4	-31.9	15.82	-28.61
Interest Expense / Income	2.92	2.25	1.76	1.33	1.38
Other Expense / Income	-0.95	-11.99	-49.46	-0.08	-0.25
Pretax Income	-35.81	-22.67	15.8	14.56	-29.74
Income Tax	0	0	0	0.35	0
Net Income	-35.81	-22.67	15.8	14.21	-29.74
Preferred Dividends	0	0	0	14.05	-15.53
Net Income Common	-35.81	-22.67	15.8	0.17	-14.21
Net Income Growth	-	-	9416.87%	-	-
Shares Outstanding (Basic)	2	2	1	0	0
Shares Outstanding (Diluted)	2	2	1	0	0
Shares Change	32.77%	14.37%	1256.16%	-78.56%	-
EPS (Basic)	-16.37	-13.76	26.25	3.00	-28.75
EPS (Diluted)	-16.37	-13.76	11.00	2.75	-28.75
EPS Growth	-	-	300.00%	-	-
Free Cash Flow	-29.65	-26.09	-24.32	13.68	-27.51
Free Cash Flow Per Share	-13.56	-15.84	-40.25	242.48	-55.55
Gross Margin	-	100.00%	100.00%	100.00%	-
Operating Margin	-	-911.99%	-2230.56%	37.66%	-
Profit Margin	-	-637.91%	1104.76%	0.40%	-
Free Cash Flow Margin	-	-734.34%	-1700.91%	32.57%	-
Effective Tax Rate	-	-	-	2.41%	-
EBITDA	-32.78	-20.36	17.59	16.06	-28.05
EBITDA Margin	-	-573.07%	1229.79%	38.23%	-
Depreciation & Amortization	0.11	0.05	0.02	0.16	0.31
EBIT	-32.89	-20.41	17.56	15.9	-28.36
EBIT Margin	-	-574.56%	1228.11%	37.85%	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).